Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

NCT01919554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis Due to House Dust Mite

Interventions

BIOLOGICAL: 500 IR house dust mites allergen extract tablet
BIOLOGICAL: 1000 IR house dust mites allergen extract tablet
BIOLOGICAL: 1500 IR house dust mites allergen extract tablet
BIOLOGICAL: Placebo tablet

Sponsor

Stallergenes Greer

Collaborators

[object Object]